Pure Global
NCT06290245

PEP Buddy Impact on Breathing, Exercise, and Sleep Quality in COPD Patients

Effect of PEP Buddy During Aerobic Training on Breathing, Exercise, and Sleep Quality in COPD Patients
Cairo University·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Pulmonary Disease, Chronic Obstructive
Drug/Device/Intervention
PEP Buddy
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Cairo University
Location
Giza, Egypt
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Dec 01, 2024
Enrollment
90 participants
Primary outcome

dyspnea

Summary

Exercise intolerance and sleeping problems are among the most common symptoms experienced by
 patients with chronic obstructive pulmonary disease (COPD), which is associated with lung
 dynamic hyperinflation (DH). There was evidence that positive expiratory pressure (PEP),
 which less costly devices could offer, could reduce DH.
 
 A positive expiratory pressure device improved COPD-related symptoms in more than 70% of
 patients with COPD.
 
 PEP buddy is an adjunct to current COPD therapies, such as inhalers and pulmonary
 rehabilitation. It provides a tool for self-management and breathing re-training, reducing
 dyspnea and improving quality of life.

ICD-10 classifications
Chronic obstructive pulmonary disease, unspecifiedOther chronic obstructive pulmonary diseaseOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease with acute exacerbation, unspecifiedChronic obstructive pulmonary disease with acute lower respiratory infection
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06290245
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06290245 through Pure Global AI's free database. This phase not specified trial is sponsored by Cairo University and is currently Recruiting. The study focuses on Pulmonary Disease, Chronic Obstructive. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.